###begin article-title 0
###xml 27 33 <span type="species:ncbi:10090">Murine</span>
IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
###end article-title 0
###begin p 1
Conceived and designed the experiments: EM BS TL. Performed the experiments: EM MD VG SC. Analyzed the data: EM MD BS TL. Contributed reagents/materials/analysis tools: EM TL. Wrote the paper: EM TL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The role of inflammation in the pathogenesis of non-alcoholic steatohepatitis (NASH), a common cause of liver disease, is still poorly understood. This study aimed at assessing the involvement of a major inflammatory cytokine, IL-6, in NASH.
###end p 3
###begin title 4
Materials and Methods
###end title 4
###begin p 5
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Steatohepatitis was induced by feeding wild-type or IL-6-/- mice for 5 weeks with a methionine and choline-deficient (MCD) diet.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 845 848 838 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
###xml 849 853 <span type="species:ncbi:10090">mice</span>
Whereas MCD diet-induced weight loss and decreases in serum glucose, cholesterol and triglyceride levels were similar in both genotypes, serum alanine aminotransferase was less elevated in IL-6-/- mice than in wild-type animals. Despite having a comparable liver steatosis score, IL-6-deficient mice exhibited less lobular inflammation than their wild-type littermates. Liver gene expression of TGF-beta and MCP-1 was also strongly attenuated in mutant mice; a more modest reduction was observed for PPAR-gamma and F4/80 transcripts as well as proteins. Chromatographic analysis of liver lipids demonstrated that MCD diet induced in normal and mutant mice a similar decrease in the ratio of phosphatidylcholine to phosphatidylethanolamine. However, the diet-induced increase in the levels of sphingomyelin and ceramide was less important in IL-6-/- mice.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
Altogether, these results indicate that IL-6 deficiency does not block the development of NASH; yet, IL-6 plays a critical role in the accompanying liver inflammation.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 86 89 86 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Ludwig1">[1]</xref>
###xml 742 745 742 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Haque1">[2]</xref>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
###xml 673 690 <span type="species:ncbi:11103">hepatitis C virus</span>
The term non-alcoholic steatohepatitis (NASH) was first used in 1980 by Ludwig et al. [1] to describe a histological pattern that mimicked alcoholic hepatitis but occurred in patients without history of alcohol abuse. The features of NASH on liver biopsy include steatosis, inflammation, liver cell injury and varying degrees of fibrosis. NASH belongs to the spectrum of non-alcoholic fatty liver disease (NAFLD) and is becoming a major public health problem because it is associated with obesity, insulin resistance and the metabolic syndrome. Therefore, NASH is believed to affect approximately 3% of adults in Western countries and represents, together with alcohol and hepatitis C virus infection, one of the main etiologies of cirrhosis [2].
###end p 11
###begin p 12
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Day1">[3]</xref>
###xml 727 730 727 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Larter1">[4]</xref>
A 'two-hit process' has been proposed to underlie the pathophysiology of NASH [3]. According to this concept, in the first hit, there is an increase of circulating free fatty acids resulting in liver steatosis. This step is enhanced by insulin resistance, which appears to play a prominent role. Secondary insults ('the second hit') include oxidative stress, whereby production of radical oxygen species and lipid peroxidation occur, recruitment of inflammatory cells and dysregulated cytokine/adipokine production. This induces hepatocyte cell death, by apoptosis or necrosis, and subsequent liver inflammation and fibrosis. A current, more integrated hypothesis suggests the involvement of multiple and interconnected events [4].
###end p 12
###begin p 13
###xml 519 522 507 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Hotamisligil1">[5]</xref>
###xml 579 582 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Yin1">[6]</xref>
###xml 667 670 651 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Crespo1">[7]</xref>
###xml 704 707 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Bahcecioglu1">[8]</xref>
###xml 988 993 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 999 1002 975 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Memon1">[9]</xref>
###xml 1056 1060 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Deng1">[10]</xref>
###xml 1143 1147 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Feldstein1">[11]</xref>
###xml 1285 1289 1261 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Tomita1">[12]</xref>
###xml 1483 1493 1459 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Discussion</xref>
###xml 725 733 <span type="species:ncbi:9606">patients</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
###xml 1087 1091 <span type="species:ncbi:10090">mice</span>
###xml 1230 1234 <span type="species:ncbi:10090">mice</span>
Whereas the molecular mechanisms leading from liver steatosis to NASH (or from NASH to cirrhosis) still remain unclear, hepatic inflammatory cell recruitment appears as a key step, and the contribution of inflammatory cytokines such as tumor necrosis factor (TNF)-alpha or interleukin-6 (IL-6) seems obvious. Nevertheless, despite recent work on TNFalpha in the pathogenesis of NASH, the role of this pro-inflammatory cytokine is still a matter of debate. TNFalpha is known to play a central role in insulin resistance [5] and is critically involved in alcoholic steatohepatitis [6]. Moreover, liver and adipose tissue TNFalpha and TNF receptor 1 (TNFR1) transcripts [7] as well as serum TNFalpha levels [8] are increased in patients with NASH. While these observations point to some contribution of TNFalpha to the pathogenesis of NASH, recent studies on animal models have led conflicting conclusions. For instance, deficiency of TNF receptors did not prevent elevation of serum ALT in ob/ob mice [9] or after intragastric overfeeding of a high-fat diet [10]. However, TNFR1-deficient mice fed a high sucrose diet did not manifest steatosis [11], and liver steatosis and fibrosis were attenuated in doubly TNFR1/TNFR2-deficient mice fed a methionine and choline-deficient (MCD) diet [12]. With regard to IL-6, a pleiotropic cytokine which regulates inflammatory responses and represents another putative mediator of steatohepatitis, its precise role in NASH is almost unknown (see Discussion).
###end p 13
###begin p 14
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-McCuskey1">[13]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Diehl1">[15]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Yao1">[16]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Rinella2">[17]</xref>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 784 789 <span type="species:ncbi:9606">human</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
The present study was therefore undertaken to clarify the place of IL-6 in the development of NASH. For this purpose, IL-6-deficient (IL6-/-) mice were analysed. We used MCD diet to induce experimental NASH because of the reproducibility of this well-established model that allows the assessment of the inflammatory pathway despite the absence of insulin-resistance [13]-[15]. This is a frequently employed nutritional model, where steatosis appears and serum ALT levels increase after 3 weeks, followed by focal inflammation and fibrosis after 5 and 8 weeks, respectively. In this model, lipid storage is believed to be the consequences of increased fatty acid uptake and decreased VLDL secretion [16], [17]. The histological changes are morphologically similar to those observed in human NASH. Our biochemical, histological and molecular analyses indicate that in mice IL-6 contributes to the MCD diet-induced liver inflammation.
###end p 14
###begin title 15
Materials and Methods
###end title 15
###begin title 16
Ethics Statement
###end title 16
###begin p 17
###xml 176 181 <span type="species:ncbi:10090">Mouse</span>
All animal experimentation was conducted in accordance with accepted standards of humane animal care (recommendations of the European Accreditation of Laboratory Animal Care). Mouse experiments were approved and performed according to the guidelines of the Toulouse University Midi-Pyrenees Regional Animal Safety Committee.
###end p 17
###begin title 18
Animal Experiments
###end title 18
###begin p 19
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Kopf1">[18]</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">Mice</span>
###xml 598 602 <span type="species:ncbi:10090">Mice</span>
Ten-week-old C57BL/6 male mice, either WT or deficient for IL-6, were fed a MCD diet (MP Biomedicals, France) or a normal diet (2016 Teklad Global 16% Protein Rodent Diet) for 5 weeks. IL-6-/- mice [18] were kindly provided by Dr. M. Thomsen (Inserm U858, Toulouse, France). Animals had unrestricted access to food and water, were housed in temperature-controlled rooms (in the specific pathogen-free animal facility of IFR31, Toulouse) and kept on a 12-hour light/dark cycle. Mice were anaesthetised with fluothane inhalation and about 300 microl of blood was collected by retro-orbital puncture. Mice were sacrificed by cervical dislocation. Livers were rapidly excised and rinsed in phosphate buffered saline (PBS). Two slides of the largest lobe were fixed in 10% formaldehyde for histological analyses and the remaining liver was immediately frozen at -80degreesC for other analyses.
###end p 19
###begin title 20
Morphologic Studies
###end title 20
###begin p 21
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Brunt1">[19]</xref>
###xml 538 542 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Kleiner1">[20]</xref>
Liver was embedded into paraffin and sections were cut and stained with hematoxylin eosin (HE), Oil Red O or Masson trichrome. Evaluation was performed by a single blinded pathologist (M.D). The criteria used were steatosis, lobular and portal inflammation, portal fibrosis, cellular ballooning, lipogranuloma, and apoptosis, according to Brunt et al. [19]. Based on these criteria, the NAFL (non-alcoholic fatty liver) Activity Score was calculated, which allows to distinguish NASH (NAFL score>/=5), borderline (3 to 4) or no NASH (<3) [20].
###end p 21
###begin p 22
Immunohistochemistry of paraffin-embedded liver sections was carried out using an anti-F4/80 antibody (MCA497, Serotec) to characterize macrophagic cells.
###end p 22
###begin title 23
Blood Tests
###end title 23
###begin p 24
Serum was collected after a 20 min centrifugation at 1000 x g. Glucose levels were measured using a Glucotrend 2(R) analyser (Roche Diagnostics, France), and triglyceride, cholesterol and ALT levels were determined using a Cobas MIRA analyser.
###end p 24
###begin title 25
Liver Lipid Analyses
###end title 25
###begin p 26
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 480 484 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Bradford1">[21]</xref>
###xml 565 569 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Folch1">[22]</xref>
A 100 mg portion of the liver was transferred into 1 ml of buffer (10 mM Hepes-KOH pH 7.4, 42 mM KCl, 5 mM MgCl2, 1 mM dithiothreitol, 0.5% CHAPS, 1 microM PMSF, and 2 microg/ml leupeptin). Liver was homogenised at 4degreesC using a Turrax homogeniser (2x10 sec), followed by sonication (2x5 sec) with a tip Soniprep sonicator. An aliquot of liver homogenate was centrifuged for 10 min at 500 x g at 4degreesC. The supernatant was used for protein analysis by the Bradford method [21] and stored for further analyses. Lipids were extracted according to Folch et al [22]. Briefly, 300 microl of distilled water and 2.5 ml of chloroform/methanol (2/1, by vol.) were added to 200 microl of liver homogenate; after vigorous mixing and centrifugation, the lower organic phase was isolated and evaporated under a nitrogen stream.
###end p 26
###begin p 27
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Ames1">[23]</xref>
###xml 535 542 535 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 575 577 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 608 612 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Bielawska1">[24]</xref>
###xml 535 542 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Total liver phospholipids were determined by measuring the content of inorganic phosphorus [23]. For quantification of sphingomyelin, the lipid extract was first submitted to mild alkaline methanolysis (to degrade acylglycerophospholipids) and resistant lipids (i.e., sphingomyelin) were reisolated for determination of the phosphorus content as described above. Individual glycerophospholipid species were separated by high performance liquid chromatography (Lipidomic core, IFR30, Toulouse). Ceramide levels were determined by using E. coli diacylglycerol kinase and [gamma32P]-ATP as previously described [24].
###end p 27
###begin title 28
Liver Lipid Peroxide Determination
###end title 28
###begin p 29
###xml 126 130 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-George1">[25]</xref>
Total lipoperoxides were measured as thiobarbituric acid-reactive substances (TBARS) in 50 and 100 microl of liver homogenate [25]. Briefly, after addition of water (to a final volume of 1 ml), 0.5N HCl (100 microl) and thiobarbituric acid (1 ml), and heating at 95degreesC in the darkness for 20 min, butanol (2 ml) was added. After centrifugation for 10 min at 500 g at 4degreesC, the fluorescence intensity of the supernatant was recorded using a Jobin-Yvon spectrofluorimeter (at 515 nm and 548 nm for the excitation and emission wavelength, respectively). TBARS were quantified using malondialdehyde (MDA) as a standard.
###end p 29
###begin title 30
Assessment of Apoptosis
###end title 30
###begin p 31
###xml 159 163 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Cuvillier1">[26]</xref>
###xml 296 302 <span type="species:ncbi:9986">rabbit</span>
Several techniques to assess apoptosis were employed. DEVDase activity was measured by fluorometry on a 100 microl aliquot of the liver homogenate supernatant [26]. Caspase-3 processing was also analysed by Western blotting. Total liver proteins (30 microg) were separated on 15% PAGE. We used a rabbit primary anti-caspase-3 antibody (Cell Signaling); complexes were revealed with a SuperSignal(R) West Dura Substrate kit (Pierce Biotechnology, USA). Finally, DNA fragmentation was studied. After an overnight digestion of 100 mg of liver with proteinase K at 55degreesC, DNA was extracted using a chloroform/phenol method. Twenty-five microg of DNA were migrated on 2% agarose gel containing ethidium bromide.
###end p 31
###begin title 32
Determination of mRNA Levels
###end title 32
###begin p 33
###xml 313 316 301 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 502 509 481 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007929-t001">Table 1</xref>
RNA extraction was performed using RNA STAT-60(R) (Ams Biotechnology, UK). cDNA was obtained using 1 microg of total RNA for reverse transcription and the Superscript II(R) Reverse Transcriptase (Invitrogen). Real-time quantitative PCR was carried out using primers for F4/80, GAPDH, HPRT, IL-6, MCP-1, PPAR-gamma1/2, TGF-beta, and TNFalpha, and with Power SYBR(R) Green PCR Master Mix (Applied Biosystems, UK). We used an ABI 7900 analyser (Applied Biosystems). Sequences for primers are indicated in Table 1.
###end p 33
###begin title 34
Sequences of primers used for quantitative RT-PCR.
###end title 34
###begin p 35
All sequences are oriented, from left to right, 5' to 3'.
###end p 35
###begin title 36
Western Blotting Analyses
###end title 36
###begin p 37
Equal amounts of proteins (50 microg) were extracted from livers, electrophoresed on a 10% SDS-polyacrylamide gel, transferred to a nitrocellulose membrane (Perkin-Elmer) and blotted with anti-Foxp3 (14-7979, eBioscience) and PPAR-gamma (sc-7273, Santa-Cruz). Proteins were detected using an ECL detection system (Thermo Scientific). Secondary antibodies were from Cell Signaling Technology.
###end p 37
###begin title 38
Data Analysis
###end title 38
###begin p 39
###xml 103 104 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 117 118 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Numerical data are expressed as means+/-SEM. Statistical analysis was performed using unpaired Student t test and Chi2 test, for continuous or categorical variables respectively. Values of p<0.05 were considered significant.
###end p 39
###begin title 40
Results
###end title 40
###begin title 41
Effects of MCD Diet on Anthropometric Parameters, Serum Glucose and Lipid Levels
###end title 41
###begin p 42
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 158 165 158 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g001">Fig. 1A</xref>
###xml 261 268 261 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g001">Fig. 1B</xref>
###xml 407 423 407 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g001">Fig. 1C, D and E</xref>
###xml 469 472 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
WT mice were slightly heavier than IL-6-/- mice but both control and mutant mice lost about one third of their initial body weight after 5 weeks of MCD diet (Fig. 1A). There was no liver enlargement and the liver weight even decreased by about 50% on MCD diet (Fig. 1B). Without fasting, MCD diet induced a marked decrease in serum glucose, triglyceride and cholesterol levels as compared to a normal diet (Fig. 1C, D and E). This decrease was comparable in WT and IL-6-/- mice. Cholesterol levels, however, remained slightly higher in mutant mice.
###end p 42
###begin title 43
MCD diet results in loss of body and liver weights, hypoglycemia, hypotriglyceridemia, hypocholesterolemia, and increased serum alanine aminotransferase (ALT) activity.
###end title 43
###begin p 44
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 559 562 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
After 5 weeks of a MCD diet, body (A) and liver (B) weights, serum levels of glucose (C), triacylglycerols (D), cholesterol (E), and ALT (F) of WT and IL-6-/- mice were determined. Data are means+/-SEM; the number of animals is indicated into each column. Asterisks denote significant differences (* p<0.05, ** p<0.01, *** p<0.001) between mice of different genotypes on the MCD diet (when indicated above the line) or between different diets for the same genotype (when indicated in A and above the columns). $$$ indicates a difference (p<0.001) between IL-6-/- and WT mice on a normal diet.
###end p 44
###begin title 45
Hepatic Injury on MCD Diet
###end title 45
###begin p 46
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g001">Fig. 1F</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
Feeding mice with MCD diet resulted in a 5.5-fold increased level of ALT. This biochemical liver injury induced by MCD diet was similar in WT and IL-6-/- mice (Fig. 1F). Increased ALT levels were already present at 3 weeks (not shown).
###end p 46
###begin p 47
###xml 99 106 99 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g002">Fig. 2A</xref>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g002">Fig. 2D</xref>
###xml 474 481 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g002">Fig. 2E</xref>
###xml 554 557 554 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 564 571 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g002">Fig. 2F</xref>
###xml 670 673 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 730 737 730 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g002">Fig. 2B</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Kleiner1">[20]</xref>
###xml 814 817 814 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 902 909 902 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g002">Fig. 2C</xref>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 1152 1156 <span type="species:ncbi:10090">mice</span>
Histological analysis revealed that the steatosis induced by MCD diet was similar for all animals (Fig. 2A). Steatosis was assessed using HE staining but also with Oil Red O (not shown). Cellular ballooning appeared quite mild and comparable for all types of mice (not shown). As illustrated in representative sections, the liver of WT mice fed the normal diet was normal (Fig. 2D) whereas on the MCD diet it contained large fat droplets and clusters of inflammatory cells (Fig. 2E). But the number of inflammatory cells and clusters were reduced in IL-6-/- mice (Fig. 2F). Indeed, the lobular inflammation detected in mice fed the MCD diet was mild to moderate for IL-6-/- mice, whereas it was moderate to severe for WT animals (Fig. 2B). Finally, after MCD feeding, the NAFL Activity Score [20] was lower in IL-6-/-mice (p = 0.04) than in WT animals, with respectively 50% and 90% of confirmed NASH (Fig. 2C). After 5 weeks on MCD diet, fibrosis could not be detected on Masson trichrome-stained sections for both genotypes (not shown). Of note, under a normal diet, the steatosis and lobular inflammation scores were similar in WT and IL6-deficient mice.
###end p 47
###begin title 48
Effect of IL-6 deficiency on MCD diet-induced steatohepatitis.
###end title 48
###begin p 49
###xml 340 343 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 482 485 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 658 661 658 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
After 5 weeks of a MCD diet, mice were sacrificed and the liver was examined for scoring steatosis (A), ballooning (not shown) and lobular inflammation (B). The NAFL (non-alcoholic fatty liver) activity score was calculated (C). Representative sections of hematoxylin/eosin-stained liver of WT mice on normal (D) or MCD diet (E), or of IL-6-/- mice on MCD diet (F), are shown. Liver sections of WT mice (E) revealed large fat droplets and the presence of inflammatory cells. In IL-6-/- mice, steatosis was similarly present, but the number of inflammatory cells was decreased. The number of animals per group was 12 and 11 for WT mice, and 10 and 10 for IL-6-/-mice fed a normal or MCD diet, respectively. * p<0.05, *** p<0.001.
###end p 49
###begin title 50
Absence of Apoptosis Associated with Steatohepatitis
###end title 50
###begin p 51
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Tomita1">[12]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Natori1">[27]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Baumgardner1">[32]</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Development of steatohepatitis, including NASH, has been shown to be associated with liver apoptosis [12], [27]-[32]. In the liver from mice fed the MCD diet for 5 weeks, we did not find any sign of apoptosis whatever the genotype and the NAFL Activity Score. Indeed, there were no increase of DEVDase (effector caspase) activity, no proteolytic cleavage of caspase-3, no DNA fragmentation, and no apoptotic bodies on histological examination. We therefore concluded that, by that time of MCD diet feeding, liver apoptosis is not a prominent phenomenon contributing to NASH.
###end p 51
###begin title 52
Alterations in Liver Lipid Metabolism
###end title 52
###begin p 53
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Li1">[33]</xref>
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Puri1">[34]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Holland1">[35]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Mari1">[36]</xref>
###xml 536 540 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Mari1">[36]</xref>
###xml 541 545 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-MalagarieCazenave2">[38]</xref>
###xml 669 676 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g003">Fig. 3C</xref>
###xml 1008 1015 1004 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g003">Fig. 3A</xref>
###xml 1197 1200 1193 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1226 1233 1222 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g003">Fig. 3D</xref>
###xml 1279 1286 1275 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g003">Fig. 3E</xref>
###xml 1596 1599 1592 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1768 1775 1764 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g003">Fig. 3F</xref>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1407 1411 <span type="species:ncbi:10090">mice</span>
###xml 1500 1504 <span type="species:ncbi:10090">mice</span>
###xml 1704 1708 <span type="species:ncbi:10090">mice</span>
Besides the storage of triacylglycerols, steatohepatitis is known to be associated with alterations in liver phospholipid metabolism [33], [34]. Insulin resistance is also associated with increased intracellular content of fatty acids and their metabolites, including ceramide [35], [36]. In addition, cytokines such as TNFalpha and IL-6, which might participate in the pathogenesis of NASH, elicit changes in sphingolipid metabolism and stimulate the production of bioactive lipids, such as ceramide, which behave as second messengers [36]-[38]. We thus analysed the glycerophospholipid and sphingolipid composition of the livers from mice fed a MCD diet. As shown in Fig. 3C, feeding for 5 weeks the MCD diet resulted in a decrease of the phosphatidylcholine to phosphatidylethanolamine (PC/PE) ratio of approximately 50%. This decrease was comparable for control and IL-6-deficient mice, although the PC levels slightly increased in WT but decreased in mutant mice, in which the basal levels were higher (Fig. 3A). Under conditions of feeding a normal diet, the liver content of total phospholipids (not shown) as well as that of sphingomyelin, the major sphingophospholipid, was higher in IL-6-/- mice than in WT animals (Fig. 3D). The same applied for the ceramide content (Fig. 3E). After 5 weeks of MCD diet, livers exhibited an increase both in the sphingomyelin and ceramide concentrations for all mice. However, whereas the content of these two lipids increased by more than 2.6-fold in WT mice (p<0.001 for sphingomyelin and ceramide), it did not increase by more than 1.5-fold in IL-6-/- animals (p<0.001 for sphingomyelin and p = 0.01 for ceramide). A lesser elevation of ceramide in mutant mice was also observed when normalizing to total phospholipids (Fig. 3F).
###end p 53
###begin title 54
Effects of IL-6 deficiency on liver lipid content.
###end title 54
###begin p 55
###xml 537 543 537 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g001">Fig. 1</xref>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
Lipids were extracted from the livers of mice fed a normal or the MCD diet for 5 weeks. Phosphatidylcholine (PC, panel A) and phosphatidylethanolamine (PE, panel B) levels were measured by HPLC, and the PC/PE ratio (C) was calculated. The levels of sphingomyelin (D) were determined by inorganic phosphorus analysis preceded of alkaline methanolysis, and those of ceramide (E) were measured by the diacylglycerol kinase assay. In panel F, ceramide is expressed as the ratio to total phospholipids. Data are expressed as in the legend to Fig. 1. Further symbols ($ p<0.05, $$ p<0.01, $$$ p<0.001) indicate differences between IL-6-/- and WT mice on a normal diet.
###end p 55
###begin title 56
Lipid Peroxidation
###end title 56
###begin p 57
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-George1">[25]</xref>
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Kirsch1">[31]</xref>
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Baumgardner1">[32]</xref>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Leclercq1">[39]</xref>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-DelaPena1">[40]</xref>
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 229 237 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g004">Figure 4</xref>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
Because NASH is often associated with lipid peroxidation [25], [31], [32], [39], [40] we next sought to assess the importance of this phenomenon in IL-6-/- mice. Liver peroxides were measured through the quantification of TBARS. Figure 4 shows that, on a normal diet the liver TBARS content was higher (p = 0.03) for IL-6-/- mice than for WT mice. As expected, these levels increased on MCD diet, but this increase was only 1.7-fold in mutant mice (p<0.001) as compared to 3.3-fold in WT mice (p<0.001).
###end p 57
###begin title 58
Effect of IL-6 deficiency on MCD diet-induced peroxidation of liver lipids.
###end title 58
###begin p 59
###xml 304 307 302 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
Total lipoperoxides were measured as TBARS. Each determination was performed in duplicate. Data are means+/-SEM; the number of animals is indicated into each column. The asterisks denote a significant difference between diets for the same genotype (***, p<0.001), and $ a difference (p<0.05) between IL-6-/- and WT mice on a normal diet.
###end p 59
###begin title 60
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 82 86 <span type="species:ncbi:10090">Mice</span>
Reduced Expression of Genes of the Inflammatory and Fibrosing Response in IL-6-/- Mice
###end title 60
###begin p 61
###xml 136 139 128 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1/2</sub>
###xml 169 176 161 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g005">Fig. 5A</xref>
###xml 211 215 199 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1, 2</sub>
###xml 262 265 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 346 353 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g005">Fig. 5B</xref>
###xml 521 524 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 650 657 635 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g005">Fig. 5C</xref>
###xml 769 772 754 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 993 996 978 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1017 1024 1002 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g005">Fig. 5D</xref>
###xml 1512 1516 1497 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Gyamfi1">[41]</xref>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1167 1171 <span type="species:ncbi:10090">mice</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
###xml 1253 1257 <span type="species:ncbi:10090">mice</span>
In accordance with the fact that steatosis is associated with hepatic expression of PPAR-gamma, MCD diet induced an increased PPAR-gamma1/2 gene expression in all mice (Fig. 5A). However, the level of PPAR-gamma1, 2 transcripts was higher in WT mice than in IL-6-/- mice, although a similar difference existed on a normal diet. As illustrated in Fig. 5B, mRNA levels of the fibrogenesis mediator TGF-beta significantly increased on MCD diet only in WT mice. The expression level of this gene was lower on MCD diet in IL-6-/- mice than in WT mice. The expression of the monocyte chemoattractant protein MCP-1 increased 11-fold on MCD diet in WT mice (Fig. 5C). Of interest, despite a modest (25-30%) increase on MCD diet, MCP-1 mRNA levels remained extremely low in IL-6-/- mice. Finally, in accordance with the decreased inflammation observed histologically, the mRNA levels of the macrophage marker F4/80 that were similar on a normal diet increased by 233 and 159% on MCD diet in WT and IL-6-/- mice, respectively (Fig. 5D). Although TNF was generally expressed at a lower level than the other genes examined, on MCD diet its levels were increased by 12-fold in WT mice but only 6-fold in IL-6-deficient mice (not shown). While undetectable in mutant mice, the level of IL-6 gene expression in WT animals was not increased after 5 weeks of MCD diet feeding (not shown). This finding would be in agreement with a recent study in which hepatic IL-6 levels were determined after 6 weeks feeding a liquid MCD diet [41] and is likely related to the fact that it was measured at a too late point.
###end p 61
###begin title 62
Effects of IL-6 deficiency on MCD diet-induced changes in liver gene expression.
###end title 62
###begin p 63
###xml 29 33 25 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1, 2</sub>
###xml 686 689 677 680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
The mRNA levels of PPAR-gamma1, 2 (A), TGF-beta (B), MCP-1 (C), and F4/80 (D) were measured by quantitative RT-PCR and normalized to the level of HPRT mRNA. Results are expressed as the percentage of the levels found in WT mice fed a normal diet. Each determination was performed in duplicate. Data are means+/-SEM; the number of animals is indicated into each column. Asterisks denote significant differences (* p<0.05, ** p<0.01, *** p<0.001) between mice of different genotypes on the same diet (when indicated above the line) or between different diets for the same genotype (when indicated above the columns). Further symbols ($ p<0.05, $$ p<0.01) indicate differences between IL-6-/- and WT mice on a normal diet.
###end p 63
###begin p 64
###xml 193 199 193 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g006">Fig. 6</xref>
###xml 328 331 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 468 476 461 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g006">Figure 6</xref>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
To test whether some of the changes observed above for mRNA translated into changes of the corresponding proteins, we performed Western blotting experiments on liver lysates. As illustrated in Fig. 6, the levels of PPAR-gamma increased in both genotypes after MCD diet feeding. However, they remained significantly lower in IL-6-/- mice. We also tested the expression of Foxp3, a master transcription factor for TGF-beta-induced differentiation of T regulatory cells. Figure 6 shows that induction of Foxp3 during the MCD diet was abolished in IL-6-deficient animals.
###end p 64
###begin title 65
Effects of IL-6 deficiency on MCD diet-induced changes in liver expression of PPAR-gamma and Foxp3.
###end title 65
###begin p 66
###xml 344 348 <span type="species:ncbi:10090">mice</span>
Equal amounts of protein (50 microg) were analyzed by Western blotting (representative images on the left panels). Densitometric analysis of the blots is presented on the right panels. Data are means+/-SEM; the number of animals is indicated into each column. Asterisks denote significant differences (* p<0.05, ** p<0.01, *** p<0.001) between mice of different genotypes on the same diet (when indicated above the line) or between different diets for the same genotype (when indicated above the columns).
###end p 66
###begin p 67
###xml 260 273 260 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g007">Fig. 7A and C</xref>
###xml 344 357 344 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007929-g007">Fig. 7B and D</xref>
###xml 420 423 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
Finally, to check the changes in F4/80 mRNA, the activation of Kupffer cells was studied histologically by examining F4/80-positive cells in the liver samples. In the animals fed a normal diet, Kupffer cells remained isolated, being only present in sinusoids (Fig. 7A and C). MCD diet feeding caused recruitment of Kupffer cells into clusters (Fig. 7B and D). While macrophage clusters seemed to be less abundant in IL-6-/- mice, the difference did not reach statistical significance (p = 0.09).
###end p 67
###begin title 68
Effect of IL-6 deficiency on Kupffer cell activation during MCD diet-induced steatohepatitis.
###end title 68
###begin p 69
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 383 386 383 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
Representative pictures of immunohistochemical detection of F4/80-positive cells in the liver of WT and IL-6-/- mice on normal (A and C) or MCD diet (B and D), respectively, are shown. Arrowheads indicate isolated Kupffer cells whereas arrows show macrophage clusters. The abundance of isolated cells and clusters was estimated in 12 and 11 livers for WT mice, and 10 and 10 for IL-6-/- mice fed a normal or MCD diet, respectively (** p<0.01, *** p<0.001 when comparing different diets for the same genotype).
###end p 69
###begin title 70
Discussion
###end title 70
###begin p 71
###xml 480 483 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Memon1">[9]</xref>
###xml 485 489 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Deng1">[10]</xref>
###xml 491 495 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Tomita1">[12]</xref>
###xml 632 636 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-McCuskey1">[13]</xref>
###xml 637 641 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Diehl1">[15]</xref>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 1027 1031 <span type="species:ncbi:10090">mice</span>
The role of inflammatory cytokines in the development of NASH has not yet been fully elucidated. Despite recent studies on different rodent models, the contribution of TNFalpha to the pathogenesis of NASH remains unclear. Indeed, studies on mice deficient for TNFalpha or its receptors using different conditions to induce liver steatosis have not led to unequivocal conclusions. The emerging idea is that TNFalpha is not a primary mediator of NASH but influences its development [9], [10], [12]. As to IL-6, its contribution to NASH has remained almost totally elusive. Using a well-established nutritional model of NASH induction [13]-[15], the present study demonstrates that IL-6 certainly participates to the NASH-associated inflammation but is dispensable for the appearance of the disease. Whereas liver inflammation was markedly reduced in mice deficient for IL-6, as revealed both histologically and by analysing gene expression, liver injury and changes in lipid composition and peroxidation still occurred in mutant mice.
###end p 71
###begin p 72
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Wallenius1">[42]</xref>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
This is the first study to shed light on the role of IL-6 in a dietary model of NASH. In this model, IL-6 does not constitute the critical driving force for NASH but appears to modulate the inflammatory response rather than the initiation of the steatosis itself. In mice, IL-6 deficiency has been reported to induce a mature-onset obesity that appears after 6 months of life [42]. In the latter study, an increase in blood triglyceride levels was found that occurred only in females. The effect of IL-6 was supposed to be central. Of note, such an effect was not observed in the present study since we used younger males that lost weight on the MCD diet and that were slightly lighter than controls. Moreover, triglyceride levels equally decreased in both genotypes fed the MCD diet. These data strongly suggest that the alterations in lipid metabolism previously described in aged IL6-deficient females do not interfere with the present findings and interpretation.
###end p 72
###begin p 73
###xml 153 157 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-DelaPena1">[40]</xref>
###xml 211 215 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Senn1">[43]</xref>
###xml 280 284 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Abiru1">[44]</xref>
###xml 292 296 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Haukeland1">[45]</xref>
###xml 320 324 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Hill1">[46]</xref>
###xml 452 456 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Pedersen1">[47]</xref>
###xml 457 461 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Pedersen2">[49]</xref>
###xml 501 504 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 658 662 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Cressman1">[50]</xref>
###xml 772 776 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Deutschman1">[51]</xref>
###xml 889 894 881 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 921 925 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Hong1">[52]</xref>
###xml 926 930 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-ElAssal1">[54]</xref>
###xml 1040 1044 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Jin1">[30]</xref>
###xml 1117 1121 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-McGettrick1">[55]</xref>
###xml 1278 1282 1270 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Kim1">[56]</xref>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
IL-6 expression is known to be stimulated upon TNFalpha-mediated activation of NF-kappaB, a transcription factor believed to play a central role in NASH [40]. Not only has IL-6 been linked to insulin resistance [43] but also IL-6 level is increased in serum of patients with NASH [44], NAFLD [45] or alcoholic hepatitis [46]. The role of IL-6 in hepatic dysfunction in general, and insulin sensitivity and NASH in particular, remains, however, unclear [47]-[49]. Indeed, administration of IL-6 to IL-6-/- mice was shown to prevent the massive liver necrosis after partial hepatectomy, suggesting an important role of this cytokine in hepatocyte regeneration [50]. Moreover, IL-6-deficient mice were highly susceptible to sepsis-induced steatosis and hepatocellular injury [51]. More recently, treatment of mice with IL-6 ameliorated steatosis in different models of fatty liver, including ob/ob mice and ethanol-fed mice [52]-[54]. Whether IL-6 plays a protective or injurious role on liver may depend on the duration of exposure to stress [30]. Furthermore, the cytokine action may be influenced by the local milieu [55] and, as examplified by the case of IL-6 on insulin sensitivity, the duality of IL-6 functions is likely tissue-specific and physiological context-dependent [56].
###end p 73
###begin p 74
###xml 1157 1161 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Korn1">[57]</xref>
###xml 1773 1777 1764 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Scheller1">[58]</xref>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
Here we show that genetic deletion of IL-6 markedly attenuates hepatic inflammation in MCD diet-induced NASH. This effect was observed both histologically and by quantitation of hepatic expression of genes that regulate the inflammatory response and promote liver fibrosis. Histologically, upon hematoxylin/eosin staining, whereas the nature of inflammatory cells (i.e., neutrophils and lymphocytes; data not shown) was similar in control and IL-6-deficient mice, there was less lobular inflammation in mutant mice. This was concordant with F4/80 staining. The most prominent difference between WT and IL-6-deficient animals was a virtually complete abrogation in mutant mice of the diet-induced increase in the expression of MCP-1 and TGF-beta, i.e., factors that recruit inflammatory cells and activate hepatic stellate cells, respectively. Along with the reduction in TGF-beta expression, the induction of Foxp3 was suppressed in IL-6-deficient mice, suggesting that in this disease model IL-6 modulates differentiation of Foxp3-positive T regulatory cells through TGF-beta production. Whether Th17 cells, whose differentiation is also modulated by IL-6 [57], are involved in NASH would require further investigation. The possibility that SOCS (suppressor of cytokine signaling) proteins, known as critical targets of IL-6 in liver, serve as downstream mediators in this dietary model of NASH needs to be investigated. Also, the cellular origin of IL-6 would deserve careful investigation. To date, the cells that produce or react to IL-6 within the liver are not really known. Both Kupffer cells and hepatocytes are candidates. The IL-6 receptor is present on hepatocytes and some leukocytes but other cells can interact with a complex of IL-6 and its soluble receptor [58].
###end p 74
###begin p 75
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Yao1">[16]</xref>
###xml 522 526 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Li1">[33]</xref>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
The present study further shows alterations in lipid homeostasis in NASH and provides novel insights into the role of these modifications to the initiation of associated inflammation. Regarding the changes in the liver content of PC and PE, which we observed and are expected because of the depletion of both choline and methionine [16], it was recently suggested that the relative depletion of PC or, perhaps more importantly, the decreased PC/PE ratio results in a loss of membrane integrity and influences liver damage [33]. Whether such a decrease in PC/PE ratio is the cause or consequence of progression to steatohepatitis was not established. Our study now indicates that the phospholipid changes precede, rather than follow, the inflammatory process since similar lipid alterations were seen in mice where inflammation is partly halted.
###end p 75
###begin p 76
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Puri1">[34]</xref>
###xml 824 831 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1047 1051 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Mari1">[36]</xref>
###xml 1053 1057 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-FernandezCheca1">[59]</xref>
###xml 1305 1308 1305 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1455 1458 1455 1458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 434 442 <span type="species:ncbi:9606">patients</span>
###xml 1309 1313 <span type="species:ncbi:10090">mice</span>
###xml 1459 1463 <span type="species:ncbi:10090">mice</span>
Whereas changes in the liver glycerophospholipid content have already been documented, this is the first study to report changes in sphingolipids, i.e., sphingomyelin and ceramide, in MCD diet-induced NASH. Irrespective of the cytokine defect, we found an elevation of hepatic levels of these two lipids. This is in accordance with a very recent lipidomic study that described a trend of increased hepatic content of sphingomyelin in patients with NASH [34]. The mechanisms and biological implications of these changes to the pathogenesis of NASH are still far from clear. It is possible that hepatocytes increase the synthesis of sphingomyelin, a membrane choline-containing phospholipid analogous to PC, to compensate for the loss of glycerophospholipids. Such synthesis of sphingomyelin probably occurs through increased de novo synthesis of ceramide, possibly because of enhanced incorporation of free fatty acids. Given the reported role of ceramide in hepatocellular death and, in general, as a bioactive lipid with pro-apoptotic properties [36], [59], it is tempting to speculate that the increased content of ceramide participates to NASH liver injury. Generation of this ceramide seems to be partially dependent on the production of inflammatory cytokines since the liver ceramide content of IL-6-/- mice did not increase as much as in WT animals. Still for unclear reasons, the basal levels of both sphingomyelin and ceramide were higher in IL-6-/- mice as compared to control animals; however, when normalized to total phospholipids, the basal ceramide levels were identical in both genotypes. Whether ceramide plays an instrumental role in the development of steatohepatitis remains to be investigated.
###end p 76
###begin p 77
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007929-Wieckowska1">[60]</xref>
###xml 261 266 <span type="species:ncbi:9606">human</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
In conclusion, the present study demonstrates that IL-6 does contribute to the inflammatory process associated with the development of NASH. Because the dietary model of NASH we used does not induce obesity or insulin resistance, i.e. important features of the human condition, future studies using different models of NASH should shed further light on the role of IL-6 in the development of steatohepatitis. Of particular interest is the recent observation that IL-6 expression is increased in the liver of patients with NASH, is associated with elevation of circulating IL-6 levels, and correlates with disease severity [60]. Further attention should thus be paid to IL-6 as a potential pathogenic mechanism in NASH.
###end p 77
###begin p 78
###xml 345 349 <span type="species:ncbi:10090">mice</span>
The authors thank M.F. Frisach, C. Nevoit, N. Therville, Dr. Y. Barreira (Animal facility, IFR31, Toulouse), J. Bertrand-Michel (Lipidomic core, IFR30, Toulouse), C. Rolland (IFR30), L. Montbrun (IFR31), and F. Capilla (Experimental Histopathology core, IFR30) for technical assistance. We also thank Dr. M. Thomsen for providing IL-6-deficient mice and Dr. J.P. Jaffrezou for critical reading.
###end p 78
###begin title 79
References
###end title 79
###begin article-title 80
###xml 30 34 <span type="species:ncbi:162683">Mayo</span>
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
###end article-title 80
###begin article-title 81
The metabolic abnormalities associated with non-alcoholic fatty liver disease.
###end article-title 81
###begin article-title 82
Steatohepatitis: a tale of two "hits"?
###end article-title 82
###begin article-title 83
Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?
###end article-title 83
###begin article-title 84
The role of TNFalpha and TNF receptors in obesity and insulin resistance.
###end article-title 84
###begin article-title 85
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice.
###end article-title 85
###begin article-title 86
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.
###end article-title 86
###begin article-title 87
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
###end article-title 87
###begin article-title 88
###xml 68 72 <span type="species:ncbi:10090">mice</span>
TNF-alpha is not the cause of fatty liver disease in obese diabetic mice.
###end article-title 88
###begin article-title 89
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Steatohepatitis induced by intragastric overfeeding in mice.
###end article-title 89
###begin article-title 90
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.
###end article-title 90
###begin article-title 91
###xml 154 158 <span type="species:ncbi:10090">mice</span>
Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.
###end article-title 91
###begin article-title 92
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
###end article-title 92
###begin article-title 93
The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance.
###end article-title 93
###begin article-title 94
Lessons from animal models of NASH.
###end article-title 94
###begin article-title 95
###xml 104 107 <span type="species:ncbi:10116">rat</span>
The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.
###end article-title 95
###begin article-title 96
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Mechanisms of steatohepatitis in mice fed a lipogenic methionine choline deficient (MCD) diet.
###end article-title 96
###begin article-title 97
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Impaired immune and acute-phase responses in interleukin-6-deficient mice.
###end article-title 97
###begin article-title 98
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
###end article-title 98
###begin article-title 99
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
###end article-title 99
###begin article-title 100
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
###end article-title 100
###begin article-title 101
A simple method for the isolation and purification of total lipides from animal tissues.
###end article-title 101
###begin article-title 102
Assay of inorganic phosphate, total phosphate and phosphatases.
###end article-title 102
###begin article-title 103
Determination of ceramides and diglycerides by the diglyceride kinase assay.
###end article-title 103
###begin article-title 104
###xml 75 78 <span type="species:ncbi:10116">rat</span>
Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis.
###end article-title 104
###begin article-title 105
Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells.
###end article-title 105
###begin article-title 106
###xml 48 53 <span type="species:ncbi:9606">human</span>
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis.
###end article-title 106
###begin article-title 107
###xml 66 71 <span type="species:ncbi:9606">human</span>
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.
###end article-title 107
###begin article-title 108
###xml 140 148 <span type="species:ncbi:9606">patients</span>
Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
###end article-title 108
###begin article-title 109
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair.
###end article-title 109
###begin article-title 110
Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
###end article-title 110
###begin article-title 111
###xml 53 56 <span type="species:ncbi:10116">Rat</span>
A New Model For Non-Alcoholic Steatohepatitis in the Rat Utilizing Total Enteral Nutrition to Overfeed a High Polyunsaturated Fat Diet.
###end article-title 111
###begin article-title 112
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
###end article-title 112
###begin article-title 113
A lipidomic analysis of nonalcoholic fatty liver disease.
###end article-title 113
###begin article-title 114
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.
###end article-title 114
###begin article-title 115
Sphingolipid signalling and liver diseases.
###end article-title 115
###begin article-title 116
Sphingolipid signalling: molecular basis and role in TNF-induced cell death.
###end article-title 116
###begin article-title 117
###xml 142 146 <span type="species:ncbi:10090">mice</span>
Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in D-galactosamine-sensitized mice.
###end article-title 117
###begin article-title 118
###xml 63 69 <span type="species:ncbi:10090">murine</span>
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
###end article-title 118
###begin article-title 119
###xml 74 80 <span type="species:ncbi:10090">murine</span>
NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
###end article-title 119
###begin article-title 120
The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.
###end article-title 120
###begin article-title 121
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Interleukin-6-deficient mice develop mature-onset obesity.
###end article-title 121
###begin article-title 122
Interleukin-6 induces cellular insulin resistance in hepatocytes.
###end article-title 122
###begin article-title 123
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
###end article-title 123
###begin article-title 124
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
###end article-title 124
###begin article-title 125
Increased plasma interleukin-6 concentrations in alcoholic hepatitis.
###end article-title 125
###begin article-title 126
Physiological roles of muscle-derived interleukin-6 in response to exercise.
###end article-title 126
###begin article-title 127
Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis.
###end article-title 127
###begin article-title 128
Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis.
###end article-title 128
###begin article-title 129
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.
###end article-title 129
###begin article-title 130
###xml 137 141 <span type="species:ncbi:10090">mice</span>
Sepsis-induced cholestasis, steatosis, hepatocellular injury, and impaired hepatocellular regeneration are enhanced in interleukin-6 -/- mice.
###end article-title 130
###begin article-title 131
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
###end article-title 131
###begin article-title 132
Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins.
###end article-title 132
###begin article-title 133
###xml 15 19 <span type="species:ncbi:10090">mice</span>
IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver.
###end article-title 133
###begin article-title 134
Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.
###end article-title 134
###begin article-title 135
Interleukin-6 and insulin resistance.
###end article-title 135
###begin article-title 136
IL-17 and Th17 Cells.
###end article-title 136
###begin article-title 137
Interleukin-6 and its receptor: from bench to bedside.
###end article-title 137
###begin article-title 138
Ceramide, tumor necrosis factor and alcohol-induced liver disease.
###end article-title 138
###begin article-title 139
###xml 58 63 <span type="species:ncbi:9606">human</span>
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
###end article-title 139
###begin p 140
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 140
###begin p 141
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from INSERM and Universite Paul Sabatier. E.M. was the recipient of a fellowship from the Societe Francaise de Pediatrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 141

